| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTP binding | RAN GUF1 SPAG1 RAB34 EIF2S3 DAPK1 EIF2S3B GNAI2 TUFM EEF1A1 EEF1A1P5 EEF1A2 | 3.56e-07 | 397 | 94 | 12 | GO:0005525 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAN GUF1 SPAG1 RAB34 EIF2S3 DAPK1 EIF2S3B GNAI2 TUFM EEF1A1 EEF1A1P5 EEF1A2 | 1.03e-06 | 439 | 94 | 12 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAN GUF1 SPAG1 RAB34 EIF2S3 DAPK1 EIF2S3B GNAI2 TUFM EEF1A1 EEF1A1P5 EEF1A2 | 1.03e-06 | 439 | 94 | 12 | GO:0019001 |
| GeneOntologyMolecularFunction | translation elongation factor activity | 2.11e-06 | 20 | 94 | 4 | GO:0003746 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 3.00e-06 | 85 | 94 | 6 | GO:0008135 | |
| GeneOntologyMolecularFunction | GTPase activity | RAN GUF1 RAB34 EIF2S3 EIF2S3B GNAI2 TUFM EEF1A1 EEF1A1P5 EEF1A2 | 4.69e-06 | 341 | 94 | 10 | GO:0003924 |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.48e-05 | 112 | 94 | 6 | GO:0090079 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAN GUF1 RAB34 EIF2S3 MCM9 MACF1 EIF2S3B GNAI2 DNAH6 TUFM EEF1A1 EEF1A1P5 EEF1A2 RAD50 | 1.53e-05 | 775 | 94 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAN GUF1 RAB34 EIF2S3 MCM9 MACF1 EIF2S3B GNAI2 DNAH6 TUFM EEF1A1 EEF1A1P5 EEF1A2 RAD50 | 3.67e-05 | 839 | 94 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAN GUF1 RAB34 EIF2S3 MCM9 MACF1 EIF2S3B GNAI2 DNAH6 TUFM EEF1A1 EEF1A1P5 EEF1A2 RAD50 | 3.72e-05 | 840 | 94 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAN GUF1 RAB34 EIF2S3 MCM9 MACF1 EIF2S3B GNAI2 DNAH6 TUFM EEF1A1 EEF1A1P5 EEF1A2 RAD50 | 3.72e-05 | 840 | 94 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.07e-04 | 230 | 94 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | actin binding | 4.27e-04 | 479 | 94 | 9 | GO:0003779 | |
| GeneOntologyBiologicalProcess | regulation of chaperone-mediated autophagy | 4.73e-06 | 8 | 92 | 3 | GO:1904714 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | VIL1 RAPGEF6 RAB34 NETO2 MACF1 SNCA EPB41L3 ZDHHC8 EPB41L1 EPB41L2 | 1.87e-05 | 422 | 92 | 10 | GO:1990778 |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 4.80e-05 | 45 | 92 | 4 | GO:0030866 | |
| GeneOntologyBiologicalProcess | chaperone-mediated autophagy | 5.58e-05 | 17 | 92 | 3 | GO:0061684 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | VIL1 RAN RAB34 BRCA1 EXPH5 SNCA F2RL1 ZDHHC8 EPB41L2 PCNT TFRC | 6.41e-05 | 591 | 92 | 11 | GO:1903829 |
| GeneOntologyBiologicalProcess | superoxide anion generation | 7.30e-05 | 50 | 92 | 4 | GO:0042554 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 1.18e-04 | 171 | 92 | 6 | GO:1904375 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 1.22e-04 | 57 | 92 | 4 | GO:0030865 | |
| GeneOntologyCellularComponent | actin cytoskeleton | VIL1 MYO7B ROR1 TOPBP1 NOX4 MACF1 DAPK1 SNCA CNN3 EPB41L2 EEF1A1 | 6.08e-05 | 576 | 95 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 1.22e-04 | 4 | 95 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | BRCA1-B complex | 1.22e-04 | 4 | 95 | 2 | GO:0070532 | |
| GeneOntologyCellularComponent | postsynapse | PSD2 SLC16A3 NETO2 C1QC MACF1 DAPK1 CNKSR2 SNCA EPB41L3 ZDHHC8 CNN3 EPB41L1 PGR TFRC | 1.98e-04 | 1018 | 95 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | egg coat | 3.03e-04 | 6 | 95 | 2 | GO:0035805 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 3.03e-04 | 6 | 95 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 3.03e-04 | 6 | 95 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 7.91e-04 | 91 | 95 | 4 | GO:0000794 | |
| GeneOntologyCellularComponent | motile cilium | 1.18e-03 | 355 | 95 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.31e-03 | 12 | 95 | 2 | GO:0031074 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.50e-03 | 108 | 95 | 4 | GO:0032587 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.77e-03 | 113 | 95 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | cytoplasmic side of lysosomal membrane | 1.79e-03 | 14 | 95 | 2 | GO:0098574 | |
| Domain | EFTu-like_2 | 2.00e-08 | 18 | 91 | 5 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 2.00e-08 | 18 | 91 | 5 | PF03144 | |
| Domain | G_TR_2 | 2.00e-08 | 18 | 91 | 5 | PS51722 | |
| Domain | TF_GTP-bd_dom | 2.71e-08 | 19 | 91 | 5 | IPR000795 | |
| Domain | G_TR_CS | 6.52e-08 | 9 | 91 | 4 | IPR031157 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 1.08e-07 | 10 | 91 | 4 | IPR009001 | |
| Domain | Transl_B-barrel | 1.82e-07 | 27 | 91 | 5 | IPR009000 | |
| Domain | G_TR_1 | 3.65e-07 | 13 | 91 | 4 | PS00301 | |
| Domain | 4_1_CTD | 4.46e-07 | 4 | 91 | 3 | PF05902 | |
| Domain | SAB | 4.46e-07 | 4 | 91 | 3 | PF04382 | |
| Domain | Band_4.1_C | 4.46e-07 | 4 | 91 | 3 | IPR008379 | |
| Domain | SAB_dom | 4.46e-07 | 4 | 91 | 3 | IPR007477 | |
| Domain | Transl_elong_EFTu/EF1A_C | 6.16e-06 | 8 | 91 | 3 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 6.16e-06 | 8 | 91 | 3 | PF03143 | |
| Domain | P-loop_NTPase | RAN GUF1 SAMD9L NWD2 RAB34 MYO7B EIF2S3 MCM9 DAPK1 GNAI2 DNAH6 TUFM EEF1A1 EEF1A2 RAD50 | 1.38e-05 | 848 | 91 | 15 | IPR027417 |
| Domain | - | RAN GUF1 SAMD9L NWD2 RAB34 MYO7B EIF2S3 MCM9 GNAI2 DNAH6 TUFM EEF1A1 EEF1A2 RAD50 | 1.44e-05 | 746 | 91 | 14 | 3.40.50.300 |
| Domain | Transl_elong_EF1A_euk/arc | 2.35e-05 | 2 | 91 | 2 | IPR004539 | |
| Domain | FA | 3.09e-05 | 13 | 91 | 3 | PF08736 | |
| Domain | FERM-adjacent | 3.09e-05 | 13 | 91 | 3 | IPR014847 | |
| Domain | FA | 3.09e-05 | 13 | 91 | 3 | SM01195 | |
| Domain | FERM_M | 7.36e-05 | 46 | 91 | 4 | PF00373 | |
| Domain | - | 9.45e-05 | 49 | 91 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 9.45e-05 | 49 | 91 | 4 | IPR019748 | |
| Domain | FERM_domain | 9.45e-05 | 49 | 91 | 4 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.02e-04 | 50 | 91 | 4 | IPR014352 | |
| Domain | FERM_1 | 1.02e-04 | 50 | 91 | 4 | PS00660 | |
| Domain | FERM_2 | 1.02e-04 | 50 | 91 | 4 | PS00661 | |
| Domain | FERM_3 | 1.02e-04 | 50 | 91 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.02e-04 | 50 | 91 | 4 | IPR019749 | |
| Domain | B41 | 1.02e-04 | 50 | 91 | 4 | SM00295 | |
| Domain | Ez/rad/moesin-like | 1.40e-04 | 21 | 91 | 3 | IPR000798 | |
| Domain | FERM_CS | 2.10e-04 | 24 | 91 | 3 | IPR019747 | |
| Domain | FERM_C | 2.68e-04 | 26 | 91 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 3.01e-04 | 27 | 91 | 3 | IPR018980 | |
| Domain | FERM_C | 3.01e-04 | 27 | 91 | 3 | SM01196 | |
| Domain | FERM_N | 5.49e-04 | 33 | 91 | 3 | IPR018979 | |
| Domain | FERM_N | 5.49e-04 | 33 | 91 | 3 | PF09379 | |
| Domain | PH_dom-like | 1.12e-03 | 426 | 91 | 8 | IPR011993 | |
| Domain | BRCT | 3.80e-03 | 19 | 91 | 2 | PF00533 | |
| Domain | HISTONE_H2B | 4.64e-03 | 21 | 91 | 2 | PS00357 | |
| Domain | Histone_H2B | 4.64e-03 | 21 | 91 | 2 | IPR000558 | |
| Domain | H2B | 4.64e-03 | 21 | 91 | 2 | SM00427 | |
| Domain | BRCT | 5.09e-03 | 22 | 91 | 2 | SM00292 | |
| Domain | - | 5.56e-03 | 23 | 91 | 2 | 3.40.50.10190 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 4.21e-05 | 72 | 76 | 5 | MM15381 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 5.13e-05 | 75 | 76 | 5 | MM15299 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.17e-04 | 47 | 76 | 4 | MM15296 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.20e-04 | 143 | 76 | 6 | MM15383 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.51e-04 | 94 | 76 | 5 | M1080 | |
| Pathway | WP_TRANSLATION_FACTORS | 1.61e-04 | 51 | 76 | 4 | MM15881 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 1.75e-04 | 97 | 76 | 5 | M27590 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 2.48e-04 | 57 | 76 | 4 | MM15298 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 2.78e-04 | 167 | 76 | 6 | M19381 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 4.01e-04 | 116 | 76 | 5 | MM15294 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 4.89e-04 | 68 | 76 | 4 | M27587 | |
| Pathway | PID_BARD1_PATHWAY | 4.97e-04 | 29 | 76 | 3 | M258 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | KPNA5 RAN POLB SGPL1 EIF2S3 UBR4 MACF1 SNCA EPB41L3 CNN3 EPB41L1 EEF1A1 EEF1A2 RAD50 | 1.04e-10 | 498 | 96 | 14 | 36634849 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAPKAP1 SPAG1 FAT1 SLC16A3 EXPH5 NRK ROR1 DAPK1 CPD ZDHHC8 VPS13B EPB41L1 EPB41L2 TFRC | 5.88e-10 | 569 | 96 | 14 | 30639242 |
| Pubmed | VIL1 H2BC1 RAN FAM114A1 SPAG1 BRCA1 UBR4 MACF1 CFAP74 ZBTB41 GNAI2 EPB41L3 SPEN F2RL1 DNAH6 TUFM EEF1A1 PCNT EEF1A2 TFRC | 2.11e-09 | 1442 | 96 | 20 | 35575683 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.56e-08 | 361 | 96 | 10 | 26167880 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 15834631 | ||
| Pubmed | MAPKAP1 GUF1 MAGOH EIF2S3 UBR4 MACF1 CPD CRYBG3 TRAPPC8 EPB41L3 VPS13B EPB41L1 PUS7 EPB41L2 SNTB2 PCNT EEF1A2 TFRC | 1.18e-07 | 1487 | 96 | 18 | 33957083 | |
| Pubmed | Band 4.1 proteins regulate integrin-dependent cell spreading. | 2.03e-07 | 5 | 96 | 3 | 22982319 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 5.86e-07 | 256 | 96 | 8 | 35777956 | |
| Pubmed | MAPKAP1 INTS10 SP3 GUF1 MAGOH BRCA1 SGPL1 EIF2S3 TOPBP1 EXOSC3 MACF1 SPEN TUFM EPB41L1 EPB41L2 SNTB2 EEF1A1P5 | 6.77e-07 | 1497 | 96 | 17 | 31527615 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VIL1 SAMD9L MXRA5 ROR1 UBR4 EXOSC3 ZBTB41 QRICH2 TUFM EPB41L2 EEF1A1 EEF1A2 | 9.10e-07 | 736 | 96 | 12 | 29676528 |
| Pubmed | 1.06e-06 | 277 | 96 | 8 | 30745168 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | RAB34 SLC16A3 GNAI2 EPB41L3 ZDHHC8 EPB41L1 EPB41L2 SNTB2 TFRC | 1.06e-06 | 377 | 96 | 9 | 38117590 |
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 7983158 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RAN SLC16A3 EIF2S3 PSMA1 UBR4 EXOSC3 MACF1 EIF2S3B SIRT5 TUFM PUS7 EPB41L2 EEF1A1 EEF1A1P5 TFRC RAD50 | 1.59e-06 | 1415 | 96 | 16 | 28515276 |
| Pubmed | RAN NWD2 SGPL1 EIF2S3 C1QC MACF1 DAPK1 EIF2S3B CNKSR2 EPB41L3 DNAH6 TUFM EPB41L1 EPB41L2 EEF1A1 EEF1A2 | 1.84e-06 | 1431 | 96 | 16 | 37142655 | |
| Pubmed | 1.99e-06 | 407 | 96 | 9 | 12693553 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RAN GUF1 FAM114A1 FAT1 RAB34 SGPL1 CPD GNAI2 EPB41L3 DNAH6 GOLGA1 TUFM EPB41L1 EPB41L2 EEF1A1 TFRC | 2.20e-06 | 1451 | 96 | 16 | 30550785 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RAN GUF1 EIF2S3 UBR4 MACF1 DAPK1 DISP1 TUFM EEF1A1 SORD EEF1A2 TFRC | 2.36e-06 | 807 | 96 | 12 | 30575818 |
| Pubmed | 2.41e-06 | 10 | 96 | 3 | 26300397 | ||
| Pubmed | 2.44e-06 | 77 | 96 | 5 | 19505873 | ||
| Pubmed | RAN UBR4 MACF1 DAPK1 CNKSR2 EPB41L3 GOLGA1 EPB41L1 EPB41L2 EEF1A1 PCNT EEF1A2 RAD50 | 2.51e-06 | 963 | 96 | 13 | 28671696 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 2.97e-06 | 143 | 96 | 6 | 30397336 | |
| Pubmed | 3.31e-06 | 11 | 96 | 3 | 19584272 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | RAN EIF2S3 GNAI2 SNCA EPB41L3 CNN3 EPB41L1 EEF1A1 EEF1A2 TFRC | 3.42e-06 | 558 | 96 | 10 | 35063084 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.76e-06 | 231 | 96 | 7 | 16452087 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RAN EIF2S3 PSMA1 TOPBP1 EXOSC3 MACF1 DNAH6 EPB41L2 EEF1A1 PCNT EEF1A2 RAD50 | 3.87e-06 | 847 | 96 | 12 | 35235311 |
| Pubmed | 4.39e-06 | 153 | 96 | 6 | 27462432 | ||
| Pubmed | Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. | 4.40e-06 | 12 | 96 | 3 | 16391231 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RAN GUF1 RAB34 SGPL1 PSMA1 UBR4 EXOSC3 MACF1 GNAI2 EPB41L3 TUFM EPB41L2 SORD TFRC RAD50 | 4.45e-06 | 1353 | 96 | 15 | 29467282 |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 22369660 | ||
| Pubmed | 6.07e-06 | 467 | 96 | 9 | 30194290 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 38212417 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20646629 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 7.54e-06 | 2 | 96 | 2 | 30782564 | |
| Pubmed | Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint. | 7.54e-06 | 2 | 96 | 2 | 12810625 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19225127 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 35741005 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 7.54e-06 | 2 | 96 | 2 | 30370994 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26212729 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 23826138 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17825975 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 28832070 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22095224 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 38220433 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19636410 | ||
| Pubmed | Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. | 7.54e-06 | 2 | 96 | 2 | 19389812 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 7945283 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16109739 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 7.54e-06 | 2 | 96 | 2 | 16325480 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 32347192 | ||
| Pubmed | 8.77e-06 | 263 | 96 | 7 | 34702444 | ||
| Pubmed | 9.05e-06 | 15 | 96 | 3 | 8812466 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RAN FAM114A1 EIF2S3 PSMA1 UBR4 MACF1 GNAI2 SNCA TUFM EPB41L1 PUS7 EPB41L2 EEF1A1 SORD EEF1A2 | 1.06e-05 | 1455 | 96 | 15 | 22863883 |
| Pubmed | MAPKAP1 RAN FAT1 COL12A1 EIF2S3 PSMA1 UBR4 EXOSC3 MACF1 CPD GNAI2 EPB41L2 SORD TFRC | 1.29e-05 | 1297 | 96 | 14 | 33545068 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | KPNA5 RAN RAB34 PSMA1 UBR4 EIF2S3B CPD GNAI2 PUS7 SNTB2 TFRC RAD50 | 1.57e-05 | 974 | 96 | 12 | 28675297 |
| Pubmed | 1.61e-05 | 18 | 96 | 3 | 36877072 | ||
| Pubmed | 1.61e-05 | 18 | 96 | 3 | 12426392 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RAN EIF2S3 PSMA1 UBR4 EXOSC3 MACF1 CNN3 TUFM EPB41L2 EEF1A1 EEF1A2 TFRC RAD50 | 1.66e-05 | 1149 | 96 | 13 | 35446349 |
| Pubmed | 1.84e-05 | 295 | 96 | 7 | 26209609 | ||
| Pubmed | 2.25e-05 | 20 | 96 | 3 | 21689717 | ||
| Pubmed | Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. | 2.25e-05 | 20 | 96 | 3 | 9828140 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11050113 | ||
| Pubmed | Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. | 2.26e-05 | 3 | 96 | 2 | 12124328 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 29726012 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11668223 | ||
| Pubmed | Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells. | 2.26e-05 | 3 | 96 | 2 | 25084169 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19559761 | ||
| Pubmed | Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones. | 2.26e-05 | 3 | 96 | 2 | 18197009 | |
| Pubmed | Protein 4.1 expression in the developing hair cells of the mouse inner ear. | 2.26e-05 | 3 | 96 | 2 | 19853587 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23880761 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 22025680 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23157317 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 37429391 | ||
| Pubmed | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. | 2.26e-05 | 3 | 96 | 2 | 26824983 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 29480000 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 18448518 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 31963223 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 22429617 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 33664298 | ||
| Pubmed | 2.28e-05 | 552 | 96 | 9 | 36293380 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SETDB1 RAN SPAG1 RAB34 PSMA1 UBR4 GNAI2 EPB41L3 CNN3 TUFM PUS7 EEF1A1 TFRC RAD50 | 2.32e-05 | 1367 | 96 | 14 | 32687490 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | VIL1 RAN FAT1 MXRA5 RAB34 PSMA1 SERPING1 CNKSR2 GNAI2 SPEN EEF1A1 SORD | 2.38e-05 | 1016 | 96 | 12 | 19056867 |
| Pubmed | RAN EIF2S3 MACF1 CPD CRYBG3 EPB41L3 CNN3 EPB41L1 EPB41L2 TFRC | 2.68e-05 | 708 | 96 | 10 | 39231216 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.69e-05 | 313 | 96 | 7 | 38270169 | |
| Pubmed | 2.74e-05 | 565 | 96 | 9 | 20458337 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 2.74e-05 | 565 | 96 | 9 | 25468996 | |
| Pubmed | H2BC1 RAN MAGOH PSMA1 EPB41L3 EPB41L2 EEF1A1 SORD EEF1A1P5 EEF1A2 TFRC | 3.12e-05 | 878 | 96 | 11 | 37223481 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 3.36e-05 | 580 | 96 | 9 | 35676659 | |
| Pubmed | 3.63e-05 | 222 | 96 | 6 | 37071664 | ||
| Pubmed | 3.95e-05 | 24 | 96 | 3 | 24489884 | ||
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 4.11e-05 | 69 | 96 | 4 | 26792178 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RAN EXPH5 SGPL1 EIF2S3 PSMA1 EXOSC3 GNAI2 SPEN TUFM EPB41L2 SNTB2 EEF1A1 RAD50 | 4.22e-05 | 1257 | 96 | 13 | 36526897 |
| Pubmed | 4.42e-05 | 601 | 96 | 9 | 33658012 | ||
| Pubmed | RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer. | 4.49e-05 | 25 | 96 | 3 | 31636387 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 11294870 | ||
| Pubmed | Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction. | 4.51e-05 | 4 | 96 | 2 | 25555914 | |
| Pubmed | CDK targets Sae2 to control DNA-end resection and homologous recombination. | 4.51e-05 | 4 | 96 | 2 | 18716619 | |
| Pubmed | mTOR Modulates Methamphetamine-Induced Toxicity through Cell Clearing Systems. | 4.51e-05 | 4 | 96 | 2 | 30647813 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 19383352 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 17599361 | ||
| Interaction | RAN interactions | KPNA5 H2BC1 RAN MAGOH BRCA1 PSMA1 SNCA SPEN TUFM EEF1A1 PCNT EEF1A2 | 2.38e-06 | 475 | 95 | 12 | int:RAN |
| Interaction | FER1L6 interactions | 3.50e-06 | 7 | 95 | 3 | int:FER1L6 | |
| Interaction | ECPAS interactions | 4.30e-06 | 337 | 95 | 10 | int:ECPAS | |
| Interaction | NRAS interactions | MAPKAP1 FAT1 RAPGEF6 EIF2S3 ROR1 MACF1 CPD EPB41L3 ZDHHC8 VPS13B EPB41L1 EPB41L2 EEF1A1 TFRC | 4.87e-06 | 699 | 95 | 14 | int:NRAS |
| Interaction | SNCA interactions | KPNA5 RAN POLB SGPL1 PSMA1 UBR4 MACF1 SNCA EPB41L3 CNN3 EPB41L1 EEF1A1 EEF1A2 RAD50 | 6.41e-06 | 716 | 95 | 14 | int:SNCA |
| Interaction | PSMD14 interactions | H2BC1 GUF1 BRCA1 EIF2S3 PSMA1 UBR4 MCM9 EIF2S3B EEF1A1 PCNT EEF1A1P5 EEF1A2 | 6.87e-06 | 527 | 95 | 12 | int:PSMD14 |
| Interaction | DNAJC5 interactions | MAPKAP1 SLC17A8 MACF1 CPD TRAPPC8 SNCA EPB41L1 EPB41L2 SNTB2 TFRC | 1.17e-05 | 378 | 95 | 10 | int:DNAJC5 |
| Interaction | GUSBP1 interactions | 1.19e-05 | 10 | 95 | 3 | int:GUSBP1 | |
| Interaction | NUMA1 interactions | SETDB1 RAN BRCA1 POLB MACF1 SNCA EPB41L3 DNAH6 EPB41L1 EPB41L2 RAD50 | 1.30e-05 | 469 | 95 | 11 | int:NUMA1 |
| Interaction | GJA1 interactions | SDK2 ROR1 MACF1 CPD TRAPPC8 ZDHHC8 VPS13B EPB41L1 EPB41L2 EEF1A1 EEF1A2 TFRC | 1.88e-05 | 583 | 95 | 12 | int:GJA1 |
| Interaction | RBBP8 interactions | 2.44e-05 | 122 | 95 | 6 | int:RBBP8 | |
| Interaction | GOLGA1 interactions | 2.56e-05 | 183 | 95 | 7 | int:GOLGA1 | |
| Interaction | MCM5 interactions | H2BC1 BRCA1 MCM9 H2BC20P SNCA PUS7 EEF1A1 EEF1A1P5 EEF1A2 RAD50 | 2.90e-05 | 420 | 95 | 10 | int:MCM5 |
| Interaction | CAV1 interactions | RAPGEF6 ROR1 MACF1 CPD GNAI2 SNCA EPB41L3 ZDHHC8 VPS13B EPB41L1 EPB41L2 SORD TFRC | 3.45e-05 | 724 | 95 | 13 | int:CAV1 |
| Interaction | RHBDD1 interactions | SERPING1 SLC17A8 C1QC MACF1 DAPK1 EPB41L3 TUFM EPB41L2 EEF1A1 | 3.75e-05 | 346 | 95 | 9 | int:RHBDD1 |
| Interaction | RHOB interactions | SPAG1 FAT1 SDK2 RAPGEF6 RAB34 SLC16A3 MACF1 CPD GNAI2 ZDHHC8 EPB41L1 EPB41L2 SNTB2 TFRC | 3.80e-05 | 840 | 95 | 14 | int:RHOB |
| Interaction | MAP1B interactions | SETDB1 MAGOH SLC16A3 EIF2S3 PSMA1 UBR4 SNCA TUFM EEF1A1 EEF1A1P5 EEF1A2 | 4.64e-05 | 539 | 95 | 11 | int:MAP1B |
| Interaction | MLLT3 interactions | 5.10e-05 | 85 | 95 | 5 | int:MLLT3 | |
| Interaction | KCNA3 interactions | RAN EXPH5 EIF2S3 C1QC MACF1 CPD CRYBG3 EPB41L3 SPEN CNN3 EPB41L1 EPB41L2 TFRC RAD50 | 5.63e-05 | 871 | 95 | 14 | int:KCNA3 |
| Interaction | ADARB2 interactions | 6.58e-05 | 17 | 95 | 3 | int:ADARB2 | |
| Interaction | MCAM interactions | MAPKAP1 RAB34 SLC16A3 GNAI2 EPB41L3 ZDHHC8 EPB41L1 EPB41L2 SNTB2 TFRC | 7.18e-05 | 468 | 95 | 10 | int:MCAM |
| Interaction | RHOF interactions | MAPKAP1 FAT1 RAB34 SLC16A3 MACF1 CPD EPB41L3 ZDHHC8 VPS13B EPB41L1 SNTB2 TFRC | 7.57e-05 | 673 | 95 | 12 | int:RHOF |
| Interaction | DLEU1 interactions | 1.09e-04 | 20 | 95 | 3 | int:DLEU1 | |
| Interaction | SPTAN1 interactions | MAGOH BRCA1 DAPK1 CNKSR2 DNAH6 CNN3 EPB41L2 PCNT EEF1A1P5 TFRC | 1.16e-04 | 496 | 95 | 10 | int:SPTAN1 |
| Interaction | SEM1 interactions | 1.18e-04 | 162 | 95 | 6 | int:SEM1 | |
| Interaction | SRPK2 interactions | MAGOH SDK2 POLB SGPL1 UBR4 SERPING1 MACF1 HERC3 SPEN DNAH6 EPB41L1 EPB41L2 | 1.37e-04 | 717 | 95 | 12 | int:SRPK2 |
| Interaction | RHOU interactions | MAPKAP1 NETO2 MACF1 CPD GNAI2 EPB41L3 ZDHHC8 EPB41L1 SNTB2 TFRC | 1.45e-04 | 510 | 95 | 10 | int:RHOU |
| Interaction | SPTBN1 interactions | 1.67e-04 | 421 | 95 | 9 | int:SPTBN1 | |
| Interaction | HDAC1 interactions | PIAS4 H2BC1 SETDB1 RAN SP3 RAPGEF6 BRCA1 UBR4 CRYBG3 EPB41L3 SPEN CNN3 PCNT EEF1A2 RAD50 | 2.03e-04 | 1108 | 95 | 15 | int:HDAC1 |
| Interaction | MYH9 interactions | MAGOH OVGP1 BRCA1 PSMA1 MACF1 GNAI2 SNCA DNAH6 CNN3 TUFM EPB41L2 SORD | 2.19e-04 | 754 | 95 | 12 | int:MYH9 |
| Interaction | NPHS2 interactions | 2.37e-04 | 64 | 95 | 4 | int:NPHS2 | |
| Interaction | ESRRB interactions | 2.42e-04 | 262 | 95 | 7 | int:ESRRB | |
| Interaction | UBE2I interactions | HIPK3 PIAS4 SETDB1 RAN SP3 BRCA1 SLC16A3 SNCA GOLGA1 POLR1H EEF1A1P5 | 2.55e-04 | 654 | 95 | 11 | int:UBE2I |
| Interaction | CDH1 interactions | RAN SPAG1 MAGOH BRCA1 SLC16A3 SGPL1 EIF2S3 MACF1 EPB41L3 CNN3 EPB41L1 EEF1A1 | 2.59e-04 | 768 | 95 | 12 | int:CDH1 |
| Cytoband | 1p32-p31 | 1.54e-04 | 9 | 96 | 2 | 1p32-p31 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 1.61e-07 | 4 | 63 | 3 | 951 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.73e-05 | 50 | 63 | 4 | 1293 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 7.14e-05 | 4 | 63 | 2 | 1335 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.19e-04 | 5 | 63 | 2 | 1336 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-03 | 160 | 63 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.40e-03 | 161 | 63 | 4 | 593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETDB1 SP3 FAT1 BRCA1 ROR1 TOPBP1 MACF1 DAPK1 CRYBG3 TRAPPC8 SPEN VPS13B NSMAF PCNT | 2.82e-06 | 856 | 96 | 14 | M4500 |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 1.74e-05 | 221 | 96 | 7 | M15835 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 1.86e-05 | 75 | 92 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-07 | 197 | 96 | 7 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-07 | 198 | 96 | 7 | d9ffc6589ed510ffa60c591f2a0fe123210f1455 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 1.31e-06 | 160 | 96 | 6 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.33e-06 | 188 | 96 | 6 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-06 | 192 | 96 | 6 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.88e-06 | 193 | 96 | 6 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.11e-06 | 195 | 96 | 6 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.49e-06 | 198 | 96 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.49e-06 | 198 | 96 | 6 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.49e-06 | 198 | 96 | 6 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.62e-06 | 199 | 96 | 6 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 156 | 96 | 5 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 2.52e-05 | 160 | 96 | 5 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 170 | 96 | 5 | 8d3c51364a332020810836e2055c60893c10d7f3 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-05 | 87 | 96 | 4 | aaca22b97a42a1c4a10c5da708d1462101814386 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-05 | 177 | 96 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-05 | 177 | 96 | 5 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.30e-05 | 179 | 96 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 180 | 96 | 5 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | MS-mono2-|MS / Condition, Cell_class and T cell subcluster | 4.65e-05 | 182 | 96 | 5 | b5a31df2d26956e83a3afebbdaef953c7bc0d4a0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-05 | 182 | 96 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-05 | 182 | 96 | 5 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | MS-mono2|MS / Condition, Cell_class and T cell subcluster | 4.65e-05 | 182 | 96 | 5 | 44deaa67b82312139eb83ab93ec41521105b116b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 183 | 96 | 5 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.90e-05 | 184 | 96 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 184 | 96 | 5 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 186 | 96 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.16e-05 | 186 | 96 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 5.16e-05 | 186 | 96 | 5 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 187 | 96 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-05 | 187 | 96 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 187 | 96 | 5 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-05 | 188 | 96 | 5 | 48dcbb424771a2f839d65b0c429ef01ad3479a4a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.43e-05 | 188 | 96 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 5.43e-05 | 188 | 96 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-05 | 188 | 96 | 5 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-05 | 191 | 96 | 5 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.14e-05 | 193 | 96 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-05 | 194 | 96 | 5 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.30e-05 | 194 | 96 | 5 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 6.30e-05 | 194 | 96 | 5 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|CTRL / Disease state, Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | be69b20afa915978c4cf2feb0bb21ab7c1f301a5 | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 6.45e-05 | 195 | 96 | 5 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-05 | 195 | 96 | 5 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 195 | 96 | 5 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 195 | 96 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 195 | 96 | 5 | a65441ab3ee1949ec14db1d2d03bb1ee80d389bd | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 195 | 96 | 5 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 6.45e-05 | 195 | 96 | 5 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 195 | 96 | 5 | 3a30479857fc2805df92655c9599389559b1995d | |
| ToppCell | LAM-Myeloid-Macrophage|LAM / Condition, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | 85abe51e47b567e6edcadfbe8cf02c2f2f0bb133 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.45e-05 | 195 | 96 | 5 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 6.45e-05 | 195 | 96 | 5 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.61e-05 | 196 | 96 | 5 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-05 | 197 | 96 | 5 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | LAM-Myeloid|LAM / Condition, Lineage and Cell class | 6.77e-05 | 197 | 96 | 5 | 050911dcce17dee539bbaf79295e614ad84e1dae | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 197 | 96 | 5 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 197 | 96 | 5 | b72dc02b76a782f08eb1350ce131b072caec1ab0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.77e-05 | 197 | 96 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.93e-05 | 198 | 96 | 5 | a41d0a6e5f9f30a48bb7fed431a3e8257f62f955 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.93e-05 | 198 | 96 | 5 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.93e-05 | 198 | 96 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.93e-05 | 198 | 96 | 5 | 30bf78d4d657cf5140549d3dbf43d4f00482e300 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 6.93e-05 | 198 | 96 | 5 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 198 | 96 | 5 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.93e-05 | 198 | 96 | 5 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-05 | 198 | 96 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 198 | 96 | 5 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.93e-05 | 198 | 96 | 5 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.10e-05 | 199 | 96 | 5 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 34199597371a20d9f1dea9ad59edfb615b14c4f6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-05 | 199 | 96 | 5 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.10e-05 | 199 | 96 | 5 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.10e-05 | 199 | 96 | 5 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 7.10e-05 | 199 | 96 | 5 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 9df2c79904dacf029ec9df1f1cde72d871189a82 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 7.10e-05 | 199 | 96 | 5 | 78db2e3b85356ed2f08794e5a97c16a220f8a076 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.10e-05 | 199 | 96 | 5 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-05 | 199 | 96 | 5 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | 50abd20eb461927fde0ec5caae501d7f2277cf78 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.10e-05 | 199 | 96 | 5 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-05 | 199 | 96 | 5 | a843bdfcb58bec5e2a94a5ec9d5b8c5e4aef15d2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 200 | 96 | 5 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| Computational | Ttranslation elongation. | 1.14e-06 | 15 | 60 | 4 | MODULE_150 | |
| Computational | Translation regulation. | 5.49e-06 | 81 | 60 | 6 | MODULE_159 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.99e-06 | 50 | 60 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes in the cancer module 32. | 3.66e-04 | 241 | 60 | 7 | MODULE_32 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 3.03e-08 | 3 | 93 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | Animal Mammary Neoplasms | 6.04e-06 | 142 | 93 | 6 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 6.04e-06 | 142 | 93 | 6 | C1257925 | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 9.83e-06 | 2 | 93 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms, Experimental | 9.97e-06 | 155 | 93 | 6 | C0024668 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.25e-05 | 45 | 93 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Carcinomatosis | 1.33e-05 | 163 | 93 | 6 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.33e-05 | 163 | 93 | 6 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.33e-05 | 163 | 93 | 6 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.33e-05 | 163 | 93 | 6 | C0205696 | |
| Disease | Carcinoma | 1.38e-05 | 164 | 93 | 6 | C0007097 | |
| Disease | Salivary Gland Neoplasms | 1.49e-05 | 47 | 93 | 4 | C0036095 | |
| Disease | Malignant neoplasm of breast | KPNA5 BRCA1 SLC16A3 ROR1 UBR4 MACF1 GNAI2 TRAPPC8 EPB41L3 SPEN VPS13B PGR TFRC | 3.20e-05 | 1074 | 93 | 13 | C0006142 |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 6.63e-05 | 25 | 93 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | hypopituitarism (implicated_via_orthology) | 1.46e-04 | 6 | 93 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 2.88e-04 | 100 | 93 | 4 | C0010606 | |
| Disease | leukodystrophy (implicated_via_orthology) | 3.49e-04 | 9 | 93 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of salivary gland | 3.91e-04 | 45 | 93 | 3 | C0220636 | |
| Disease | Chronic Lymphocytic Leukemia | 7.06e-04 | 55 | 93 | 3 | C0023434 | |
| Disease | ovarian cancer (is_implicated_in) | 7.44e-04 | 56 | 93 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 8.72e-04 | 14 | 93 | 2 | C0677776 | |
| Disease | Alobar Holoprosencephaly | 1.00e-03 | 15 | 93 | 2 | C0431363 | |
| Disease | Lobar Holoprosencephaly | 1.15e-03 | 16 | 93 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 1.15e-03 | 16 | 93 | 2 | C0751617 | |
| Disease | Holoprosencephaly | 1.30e-03 | 17 | 93 | 2 | C0079541 | |
| Disease | Mammary Carcinoma, Human | 1.38e-03 | 525 | 93 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.38e-03 | 525 | 93 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 1.41e-03 | 527 | 93 | 7 | C1458155 | |
| Disease | Breast Carcinoma | 1.58e-03 | 538 | 93 | 7 | C0678222 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.09e-03 | 80 | 93 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | sex interaction measurement, bilirubin measurement | 2.18e-03 | 22 | 93 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.59e-03 | 24 | 93 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | aggressive behavior | 2.81e-03 | 25 | 93 | 2 | EFO_0003015 | |
| Disease | breast cancer (implicated_via_orthology) | 2.81e-03 | 25 | 93 | 2 | DOID:1612 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLFGHSGSGKTTLVE | 691 | P53355 | |
| GFGSKTRSIHVKSGV | 2601 | Q68DQ2 | |
| EASGTVEKVGSSVKH | 71 | Q00796 | |
| VTTITGIEFGIKHSL | 481 | Q96F81 | |
| ASGTFLHTKVVIETG | 156 | O15131 | |
| EVEIKGTKHGSSATY | 1046 | Q9ULI1 | |
| TGKTTFVKRHLTGEF | 21 | P62826 | |
| QEHRTGTVGFKISKV | 41 | Q9BZG1 | |
| IEKVQIHFGGSTKAS | 1506 | Q9H0J4 | |
| FKTLEGVITRTKHGE | 111 | Q92878 | |
| HTVTRGITKGVKEDF | 661 | Q9NVR2 | |
| FDGVVSKGDKIVSAH | 276 | Q8N442 | |
| HFDVDKGTGTIIVAK | 1401 | Q14517 | |
| STTTHVTKTVKGGFS | 806 | Q9H4G0 | |
| FGVSKEKTTSTSLHV | 116 | P23467 | |
| HVIASKTGAESKITA | 246 | Q92805 | |
| SKGSFQGHLTTSVKE | 151 | Q6DN03 | |
| IVGTHKFSSAIGLVL | 346 | O15427 | |
| VTLSGKKVTGHILVS | 361 | P16233 | |
| KVAVAGAAGKSSEHV | 341 | Q8IYT1 | |
| EEHTAVLTKSGGVFT | 251 | Q15034 | |
| VIGDEHISFTTSKIG | 91 | P61326 | |
| TTTTHITKTVKGGIS | 936 | O43491 | |
| TSHFVFVIEVKTKGG | 36 | Q15080 | |
| LVFGIKEVTSTVLHG | 1376 | O94854 | |
| LHKVKTTSTFSVSGD | 1226 | Q8NEV8 | |
| GTSSKIEHFISILGK | 141 | Q6NSJ5 | |
| VDHGKTTLTAAITKI | 66 | P49411 | |
| QGSATVGLKSKTHAV | 31 | P25786 | |
| KVIDFGSASHVSKTV | 341 | Q9H422 | |
| HKTQGTLEGFKVETA | 1331 | O95613 | |
| TETKATFGVHLKIVG | 361 | Q9NPH5 | |
| KVGDSSGTAAAHKVL | 171 | P06401 | |
| KVDGTSHVTGKGVTV | 41 | P55085 | |
| SHVTGKGVTVETVFS | 46 | P55085 | |
| VVKELSSFTLGTGVH | 1791 | P38398 | |
| GVKVVTFCGHTSKTN | 186 | P02747 | |
| GELAKHAVSEGTKAV | 106 | Q96A08 | |
| KGHSKTFTTSLENVG | 316 | A4D1B5 | |
| LAVKHSVLFTGITGV | 2086 | Q9C0G6 | |
| GSFHKVHIVVTSKSV | 2646 | Q99715 | |
| VDSGKSTTTGHLIYK | 16 | Q05639 | |
| VDSGKSTTTGHLIYK | 16 | P68104 | |
| AVLGDFGSSTKHVIT | 116 | Q4KMG0 | |
| KHVITAEEKSAGFIG | 126 | Q4KMG0 | |
| HIGVKGFVKDSITGS | 381 | O75976 | |
| VHQALKGFTTKGVTS | 206 | P05155 | |
| VDSGKSTTTGHLIYK | 16 | Q5VTE0 | |
| IDSKKHITVFGSTEG | 511 | A6NNW6 | |
| HFTKAKSGGISLIFS | 96 | Q92636 | |
| ISKTEGKDIAFIVHG | 221 | A6NC97 | |
| AHGKSTVVKAISGVH | 51 | Q2VIR3 | |
| GELAKHAVSEGTKAV | 101 | A0A2R8Y619 | |
| EGQTLTVTSGAKKSH | 391 | Q92622 | |
| DSIHVGFVSGLKKFT | 851 | Q58EX2 | |
| VHFITDTLSKGETKF | 221 | P06746 | |
| HVIGIVTAKSGDIFK | 116 | Q9NQT5 | |
| APSVVVTSHKGKTIF | 1236 | Q9C0B2 | |
| VTSHKGKTIFNFGDV | 1241 | Q9C0B2 | |
| TTTTTHITKTVKGGI | 1016 | Q9Y2J2 | |
| ASATVGHGLTAVKEK | 141 | Q8IWE2 | |
| ETVSLGKHTVALGEK | 456 | Q12889 | |
| KTKDVGHFLSVTGTV | 116 | Q9NXL9 | |
| LGLHEKTGAFTAVKV | 41 | Q7Z2Y5 | |
| GSKTKEGVVHGVATV | 41 | P37840 | |
| EGVVHGVATVAEKTK | 46 | P37840 | |
| VLGTTEEISGKKHTE | 1211 | Q8TEU7 | |
| RIKKIESHFGSGVAS | 126 | Q7Z5M5 | |
| HGEIVGVKITSKAAF | 246 | Q8IVG5 | |
| KTTGIVETHFTFKDL | 181 | P04899 | |
| KHGLTEADVGITKFV | 106 | Q96PZ0 | |
| EGKVVKTSVVFHQLG | 51 | Q9P1U0 | |
| SKFDGKGHVGTTATK | 161 | Q9BPZ7 | |
| KAGVFEQITKTHGTI | 336 | Q8NC67 | |
| ATVTGKLVHANFGTK | 226 | P02786 | |
| VKSTRGFALKSTHGI | 1161 | Q15047 | |
| GFALKSTHGIAIKST | 1166 | Q15047 | |
| VKGVTSISADTHKYG | 341 | O95470 | |
| IKSTYDGLHVITGTT | 231 | Q8WXI2 | |
| AGLAKTKGFHTTIDI | 126 | Q15417 | |
| GKEVVSSTGVLFVKF | 136 | Q01973 | |
| SGLGKTHTVGSVAKV | 356 | P09327 | |
| KFGKVTSVQIHGTSE | 361 | Q96T58 | |
| ALSQGHVTGSKTTKD | 751 | Q9BQI7 | |
| TTELVHFIKGEKGDT | 4261 | Q15413 | |
| KKGIHSSSTVLASVE | 706 | Q02447 | |
| GKEFSAHKVVVAVGS | 96 | Q5SVQ8 | |
| GFGTTKTFKIPIEHL | 11 | Q07617 | |
| FVGRSKSGLKHELVT | 26 | Q8N2W9 | |
| GTTSFVKHISKGTLT | 3696 | Q7Z7G8 | |
| SSGVLKSHEKTHTGV | 1006 | Q9UL36 | |
| GVKEFHIVQVSSSSK | 1116 | Q9Y2L5 | |
| RHTLVKKVSGVGGTT | 746 | Q9ULC8 | |
| ATSTAGGSKEVKHIA | 316 | Q13425 | |
| KHIVIISGAGVSAES | 51 | Q9NXA8 | |
| IGSHTISKVTVKIGD | 3566 | Q5T4S7 | |
| VSVTHLIAGEVGSKK | 141 | Q92547 | |
| HKTAGDVGSKAVAAV | 706 | Q05996 | |
| ATLLLVVGFSHTKGV | 401 | Q8NDX2 | |
| AHGKSTVVKAISGVH | 51 | P41091 | |
| HFTVGITVTKKGSGL | 661 | Q9NR99 | |
| STHKTGVAIGGIIKE | 16 | Q6PIF6 |